Clinical factors associated with bacterial resistance derived from health care in Chihuahua, Mexico.
Main Article Content
Abstract
Objective: Describe the profile of Multidrug Resistance (MDR), Extended Resistance (XDR) and Pan-Resistance (PDR) to antibacterials and identify the associated clinical factors in a hospital in Chihuahua, Mexico.
Materials and methods: An observational, analytical, case-control study was carried out during the period from January 2018 to December 2020. From 308 clinical records, 506 bacteria were isolated, the variables included previous admission and treatment, days of hospital stay, site of infection, days of antibiotic use, use of 2 or more antibiotics, relationship with nosocomial infection, coinfection, admission service, and reason for admission. Descriptive analysis, Xi2 and logistic regression were performed to search for association with bacterial resistance.
Results: 56 and 44% of the isolates were gram negative and positive. Significant risk factors were days of hospital stay, previous antibiotic use, nosocomial infection, antibiotic use for more than 10 days, use of two or more antibiotics, and coinfection; the latter four being an independent risk factor for bacterial multiresistance.
Conclusion: The surgery, internal medicine and pediatric services deserve special attention due to the high proportion of multi-resistant isolates and the presence of pan-resistance, in the same way, previous admission, previous treatment and days of antibiotic use were identified as risk factors for multi-resistance. derived from the prescription and therefore, subject to modification.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Vanegas-múnera JM, Jiménez-quiceno JN. Resistencia antimicrobiana en el siglo xxi : ¿ hacia una era postantibiótica ? Rev Fac Nac Salud Pública Vol 38 No 1. 2020;1–6.
II. Hu XY, Logue M, Robinson N. Antimicrobial resistance is a global problem – a UK perspective. Eur J Integr Med [Internet]. 2020;36(April):101136. Available from:
https://doi.org/10.1016/j.eujim.2020.101136
III. Maillard JY, Bloomfield SF, Courvalin P, Essack SY, Gandra S, Gerba CP, et al. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper. Am J Infect Control. 2020;48(9):1090–9.
IV. Abushaheen MA, Muzaheed, Fatani AJ, Alosaimi M, Mansy W, George M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Disease-a-Month. 2020;66(6).
V. Agrawal M, Rattan A. How to Treat Sepsis in the Background of Resistance?: Role of Pharmacodynamics / Pharmacokinetics in Treating Sepsis. Vol. 87, Indian Journal of Pediatrics. Springer; 2020. p. 111–6.
VI. Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: A cross-study. Vol. 807, Science of the Total Environment. Elsevier B.V.; 2022.
VII. Camacho-Silvas LA, Portillo-Gallo JH, Rivera-Cisneros AE, Sánchez-González JM, Franco-Santillán R, Duque-Rodríguez J, et al. Multidrug, extended and pan-resistance to antimicrobials at the North of México. Cirugia y Cirujanos (English Edition). 2021 Aug 1;89(4):426–34.
VIII. Organización Panamericana de la Salud / Organización Mundial de la Salud. Alerta Epidemiológica: Emergencia e incremento de nuevas combinaciones de carbapenemasas en Enterobacterias en Latinoamérica y el Caribe [Internet]. 2021. Available from: www.paho.org
IX. Camacho-Silvas LA, Portillo-Gallo JH, Rivera-Cisneros AE, Sánchez-González JM, Franco-Santillán R, Duque-Rodríguez J, et al. Clinical factors associated to bacterial resistance at the North of Mexico. Revista Mexicana de Patología Clínica y Medicina de Laboratorio. 2020;67(4):205–9.
X. Padilla Serrano A, Serrano Castañeda JJ, Carranza Gonzalez R, Garcia Bonillo MP. Factores de riesgo de colonizacion por enterobacterias multirresistentes e impacto clínico. Official journal of the Spanish Society of Chemotherapy. 2018;
XI. Lim CLL, Chua AQ, Teo JQM, Cai Y, Lee W, Kwa ALH. Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis. International Journal of Infectious Diseases [Internet]. 2018;76:48–57. Available from: https://doi.org/10.1016/j.ijid.2018.05.017
XII. Cucci M, Wooten C, Fowler M, Mallat A, Hieb N, Mullen C. Incidence and Risk Factors Associated with Multi-Drug-Resistant Pathogens in a Critically Ill Trauma Population: A Retrospective Cohort Study. Surg Infect (Larchmt). 2020 Feb 1;21(1):15–22.
XIII. Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, et al. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017. New England Journal of Medicine. 2020 Apr 2;382(14):1309–19.
XIV. Thamlikitkul V, Rattanaumpawan P, Sirijatuphat R, Wangchinda W. Integrated one-day surveillance of antimicrobial use, antimicrobial consumption, antimicrobial resistance, healthcare-associated infection, and antimicrobial resistance burden among hospitalized patients in Thailand. Journal of Infection. 2020 Jul 1;81(1):98–106.
XV. Langford BJ, Quirk J, Carey S, Daneman N, Garber GE. Influencing duration of antibiotic therapy: A behavior change analysis in long-term care. Am J Infect Control [Internet]. 2019;47(12):1409–14. Available from:
https://doi.org/10.1016/j.ajic.2019.05.020
XVI. Silva ACB e., Anchieta LM, Rosado V, Ferreira J, Clemente WT, Coelho JS, et al. Antimicrobial use for treatment of healthcare-associated infections and bacterial resistance in a reference neonatal unit. J Pediatr (Rio J). 2021 May 1;97(3):329–34.
XVII. Meza A, Cruz E, Rodríguez P, Ramírez J, Solórzano F, Miranda M, et al. Estado Actual de la Resistencia Antimicrobiana en México. Programa Universitario de Investigación en Salud. 2018;28.
XVIII. Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, Rodríguez-Álvarez M, Solórzano-Santos F, Soto-Hernández JL, et al. Antimicrobial resistance and antibiotic consumption in Mexican hospitals. Salud Publica Mex. 2019;62(1, ene-feb):42.